← Back to Search

Anti-infective

Intranasal Povidone Iodine for Asymptomatic Colonization

Phase 4

Recruiting

Led By Mary K. Hayden, MD

Research Sponsored by Mary K Hayden

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

History of C. auris colonization or infection

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion and data analysis in three years (2028)

Awards & highlights

Study Summary

This trial will test whether using a specific type of antiseptic in the nose can help in detecting a type of fungus called Candida auris.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had a C. auris infection or been colonized by it.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion and data analysis in three years (2028)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion and data analysis in three years (2028)

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion and data analysis in three years (2028) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Detection of C. auris from the anterior nares

Secondary outcome measures

Detection of C. auris from body sites other than anterior nares

Detection of C. auris from environmental surfaces

Detection of MRSA from environmental surfaces

+1 more

Other outcome measures

Change in microbiome community

Non-susceptibility of C. auris to povidone iodine

Trial Design

2Treatment groups

Active Control

Group I: Intranasal Povidone IodineActive Control1 Intervention

Nasal iodophor applied twice daily for five days.

Group II: ControlActive Control1 Intervention

Routine care.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

RML Specialty HospitalOTHER

4 Previous Clinical Trials

811 Total Patients Enrolled

Mary K HaydenLead Sponsor

Rush University Medical CenterOTHER

422 Previous Clinical Trials

163,381 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of participants being recruited for this research study?

"Affirmative. Per clinicaltrials.gov, this investigation is presently in search of suitable candidates. This trial was initially disclosed on January 29th, 2024 and last revised on February 20th, 2024. The aim is to enroll a total of 120 individuals from three distinct sites."

Answered by AI

Has the FDA granted approval for Intranasal Povidone Iodine?

"Our team at Power rates the safety of Intranasal Povidone Iodine as a 3 on our scale, signifying that this Phase 4 trial involves an approved treatment."

Answered by AI

Are participants currently being sought for this study?

"Based on details provided by clinicaltrials.gov, this study is actively seeking participants. The trial was first listed on January 29th, 2024, and most recently revised on February 20th, 2024."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Nasal Antisepsis for C. Auris Prevention

Mary K Hayden 2024. "Nasal Antisepsis for C. Auris Prevention". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06282510.

All > Chicago > Milwaukee